Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Josh Neman, Rahul JandialDivision of Neurosurgery, City of Hope National Cancer Center, Duarte, CA, USAAbstract: Gliomas remain one of the most challenging solid organ tumors to treat and are marked clinically by invariable recurrence despite multimodal intervention (surgery, chemotherapy, radiation...
Guardado en:
Autores principales: | Josh Neman, Rahul Jandial |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff725080636c46bf8b798680ec23244e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering
por: Neman J, et al.
Publicado: (2012) -
Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements
por: Michael L Levy, et al.
Publicado: (2009) -
The role of stem cells in tumor targeting and growth suppression of gliomas
por: Eskandary H, et al.
Publicado: (2011) -
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
por: Orza A, et al.
Publicado: (2013) -
Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo
por: Chu SH, et al.
Publicado: (2012)